RecruitingNCT07456969
58
studies recruiting now
as of 7 Sept 2026
1,477
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
9 Mar 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT00001645
Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
RecruitingNCT03937817
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
RecruitingNCT02639299
Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge
RecruitingNCT01168271
Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 58 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Malaria study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Malaria
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
37 approved treatments and 63 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Pyrimethamine (Daraprim)Approved: Cycloguanil PamoateApproved: Hydroxychloroquine Sulfate (Hydroxychloroquine sulfate)Approved: ChlorproguanilApproved: Chloroquine Phosphate (Aralen)Approved: HalofantrineApproved: Artenimol (Artenimol component of eurartesim dihydroartemisinin)Approved: Meprobamate (Amosene)Approved: Artesunate (Arsumax)Approved: ProguanilApproved: Sulfadiazine (Coco-diazine)Approved: TafenoquineApproved: (S,S)-MefloquineApproved: Doxycycline (Doxirobe)Approved: QuinineApproved: Primaquine Phosphate (Camden)Approved: ArtemotilApproved: FosmidomycinApproved: Quinidine Gluconate (Duraquin)Approved: SulphadoxineApproved: AmodiaquineApproved: Triclosan (Aquasept)Approved: Lumefantrine (Lumefantrine component of coartem)Approved: PyronaridineApproved: Artemether (Artemether component of coartem)Approved: PiperaquineApproved: Atovaquone (Atovaquone)Approved: ArtemisininApproved: Piperaquine TetraphosphateApproved: PrimaquineApproved: Oz277Approved: Proguanil Hydrochloride (Paludrine)Approved: MefloquineApproved: ChloroquineApproved: HydroxychloroquineApproved: Tafenoquine Succinate (Arakoda)Approved: Mefloquine Hydrochloride (Fansimef)
Phase 3Insulin Glargine (Abasaglar)
Phase 3Albendazole (Albenza)
Phase 3Sulfadoxine (Sulfadoxine component of fansidar)
Phase 3Prasterone (Dhea)
Phase 3Mannitol (Aridol kit)
Phase 3Folic Acid (Bio science)
Phase 3Dapsone (Aczone)
Phase 3Pafuramidine
+ 55 more in development
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).